Patient and graft survival and episodes of biopsy-confirmed acute rejection were similar for all treatment groups , and no statistically significant differences were observed between groups in the incidence of new-onset diabetes or cardiac conditions , or in the prevalence of hyperglycemia , hypertension , or hyperlipidemia among patients who did not have these conditions at baseline .
